Article
Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure.
The American journal of medicine - 15 May 2004
Cicoira Mariantonietta, Rossi Andrea, Bonapace Stefano, Zanolla Luisa, Perrot Andreas, Francis Darrel P, Golia Giorgio, Franceschini Lorenzo, Osterziel Karl J, Zardini Piero
Abstract excerpt
BACKGROUND: Angiotensin-converting enzyme (ACE) is involved in the pathophysiology of chronic heart failure, and its activity is determined in part by a polymorphism of the ACE gene. We hypothesized that the benefits of spironolactone, which inhibits downstream elements of ACE-mediated abnormalities, may depend on ACE genotype. METHODS: We randomly assigned 93 chronic heart failure patients to treatment with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
